Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
European autonomy - military, technological, economic, and financial - is beginning to take shape as Europe hedges against current and future fluctuations in [U.S.] policy.